DK1521572T3 - Biologisk nedbrydelig film til indförsel af öjenlægemiddel - Google Patents
Biologisk nedbrydelig film til indförsel af öjenlægemiddelInfo
- Publication number
- DK1521572T3 DK1521572T3 DK03764333T DK03764333T DK1521572T3 DK 1521572 T3 DK1521572 T3 DK 1521572T3 DK 03764333 T DK03764333 T DK 03764333T DK 03764333 T DK03764333 T DK 03764333T DK 1521572 T3 DK1521572 T3 DK 1521572T3
- Authority
- DK
- Denmark
- Prior art keywords
- import
- biodegradable film
- eye drug
- film
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39584002P | 2002-07-15 | 2002-07-15 | |
US43272102P | 2002-12-12 | 2002-12-12 | |
PCT/US2003/020706 WO2004006889A1 (en) | 2002-07-15 | 2003-06-30 | Bioerodible film for ophthalmic drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1521572T3 true DK1521572T3 (da) | 2009-05-04 |
Family
ID=30118549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03764333T DK1521572T3 (da) | 2002-07-15 | 2003-06-30 | Biologisk nedbrydelig film til indförsel af öjenlægemiddel |
Country Status (17)
Country | Link |
---|---|
US (1) | US8084054B2 (da) |
EP (1) | EP1521572B1 (da) |
JP (1) | JP4454019B2 (da) |
KR (1) | KR101003514B1 (da) |
CN (1) | CN100500221C (da) |
AT (1) | ATE424187T1 (da) |
AU (1) | AU2003247671B2 (da) |
CA (1) | CA2491312C (da) |
CY (1) | CY1109606T1 (da) |
DE (1) | DE60326455D1 (da) |
DK (1) | DK1521572T3 (da) |
ES (1) | ES2321083T3 (da) |
MX (1) | MXPA05000631A (da) |
PL (1) | PL206379B1 (da) |
PT (1) | PT1521572E (da) |
SI (1) | SI1521572T1 (da) |
WO (1) | WO2004006889A1 (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0609432A2 (pt) * | 2005-03-21 | 2010-04-06 | Macusight Inc | sistemas de distribuição de fármacos para tratamento de doenças ou condições |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
WO2009140246A2 (en) | 2008-05-12 | 2009-11-19 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
CN102365109B (zh) | 2009-01-29 | 2015-06-03 | 弗赛特影像4股份有限公司 | 后段给药 |
CN103189097B (zh) * | 2010-07-29 | 2016-01-06 | 参天制药株式会社 | 带药剂的支承体及其制造方法 |
US9033911B2 (en) | 2010-08-05 | 2015-05-19 | Forsight Vision4, Inc. | Injector apparatus and method for drug delivery |
JP6111194B2 (ja) | 2010-08-05 | 2017-04-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | 組み合わせ薬物送達方法および装置 |
CA2807554C (en) | 2010-08-05 | 2021-10-26 | Forsight Vision4 Inc. | Implantable therapeutic device |
WO2012068549A2 (en) | 2010-11-19 | 2012-05-24 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
JPWO2012153870A1 (ja) * | 2011-05-11 | 2014-07-31 | 帝人株式会社 | 緑内障治療材 |
US20120302954A1 (en) * | 2011-05-25 | 2012-11-29 | Zhao Jonathon Z | Expandable devices coated with a paclitaxel composition |
US10398592B2 (en) | 2011-06-28 | 2019-09-03 | Forsight Vision4, Inc. | Diagnostic methods and apparatus |
EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE |
RS61758B1 (sr) | 2011-09-16 | 2021-05-31 | Forsight Vision4 Inc | Aparati za razmenu tečnosti |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
EP2874824A1 (en) | 2012-07-23 | 2015-05-27 | Crayola LLC | Dissolvable films and methods of using the same |
AU2014236455B2 (en) | 2013-03-14 | 2018-07-12 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
JP6385423B2 (ja) | 2013-03-28 | 2018-09-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | 治療物質送達用の眼移植片 |
KR102416726B1 (ko) | 2014-07-15 | 2022-07-05 | 포사이트 비젼4, 인크. | 안구 이식물 전달 디바이스 및 방법 |
SG11201700943TA (en) | 2014-08-08 | 2017-03-30 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
BR112017009660A2 (pt) | 2014-11-10 | 2017-12-19 | Forsight Vision4 Inc | dispositivos de administração de fármacos expansíveis e métodos de utilização |
AU2016355345A1 (en) | 2015-11-20 | 2018-05-31 | Forsight Vision4, Inc. | Porous structures for extended release drug delivery devices |
CN109195556B (zh) | 2016-04-05 | 2021-03-26 | 弗赛特影像4股份有限公司 | 可植入眼睛药物递送装置 |
JP7314155B2 (ja) | 2017-11-21 | 2023-07-25 | フォーサイト・ビジョン4・インコーポレーテッド | 膨張可能ポート送達システムのための流体交換装置及びその使用方法 |
USD1033637S1 (en) | 2022-01-24 | 2024-07-02 | Forsight Vision4, Inc. | Fluid exchange device |
WO2024059952A1 (en) * | 2022-09-23 | 2024-03-28 | Madd Ophthalmics Ltd. | Mucoadhesive drug delivery systems and methods of use |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6042766B2 (ja) | 1978-12-09 | 1985-09-25 | 日本化薬株式会社 | 基剤 |
GB8524421D0 (en) | 1985-10-03 | 1985-11-06 | Boots Co Plc | Therapeutic agents |
US4880636A (en) * | 1988-05-13 | 1989-11-14 | Franz Robert M | Film coated tablet of ranitidine HCl |
US4865846A (en) | 1988-06-03 | 1989-09-12 | Kaufman Herbert E | Drug delivery system |
US6117425A (en) | 1990-11-27 | 2000-09-12 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, method of their production and use |
US6525214B1 (en) | 1991-05-13 | 2003-02-25 | Bernard John Armitage | Therapeutic agent |
GB9213077D0 (en) | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
US5614549A (en) | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US5665382A (en) | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
EP0693924B2 (en) | 1993-02-22 | 2008-04-09 | Abraxis BioScience, Inc. | Methods for (in vivo) delivery of biologics and compositions useful therefor |
US5362478A (en) | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
TW406020B (en) | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
US5433951A (en) | 1993-10-13 | 1995-07-18 | Bristol-Myers Squibb Company | Sustained release formulation containing captopril and method |
US5484608A (en) * | 1994-03-28 | 1996-01-16 | Pharmavene, Inc. | Sustained-release drug delivery system |
US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
US6063116A (en) | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
US5783178A (en) | 1994-11-18 | 1998-07-21 | Supratek Pharma. Inc. | Polymer linked biological agents |
US6369116B1 (en) | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
RU2086218C1 (ru) | 1995-07-26 | 1997-08-10 | Санкт-Петербургская медицинская академия последипломного образования | Способ лечения глаукомы |
US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
BR9710682A (pt) | 1996-05-24 | 1999-08-17 | Angiotech Pharm Inc | Composi-{es e m-todos para tratar ou prevenir doen-as das vias do organismo |
US5888493A (en) * | 1996-12-05 | 1999-03-30 | Sawaya; Assad S. | Ophthalmic aqueous gel formulation and related methods |
CN100462066C (zh) | 1997-06-27 | 2009-02-18 | 美国生物科学有限公司 | 药剂的新制剂及其制备和应用方法 |
US6004573A (en) | 1997-10-03 | 1999-12-21 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
US20020164374A1 (en) | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
US6146659A (en) | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6017948A (en) | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
DK1161228T3 (da) * | 1999-03-16 | 2003-11-24 | Merck Patent Gmbh | Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form |
WO2000064437A1 (en) | 1999-04-22 | 2000-11-02 | American Biosciences, Inc. | Long term administration of pharmacologically active agents |
US6306120B1 (en) | 1999-06-07 | 2001-10-23 | Ben Gee Tan | Applicator and method for delivery of mitomycin to eye tissues during glaucoma filtering surgery |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
CA2445763A1 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
-
2003
- 2003-06-30 DE DE60326455T patent/DE60326455D1/de not_active Expired - Lifetime
- 2003-06-30 CN CNB038167921A patent/CN100500221C/zh not_active Expired - Fee Related
- 2003-06-30 WO PCT/US2003/020706 patent/WO2004006889A1/en active Application Filing
- 2003-06-30 MX MXPA05000631A patent/MXPA05000631A/es active IP Right Grant
- 2003-06-30 US US10/610,090 patent/US8084054B2/en not_active Expired - Fee Related
- 2003-06-30 SI SI200331565T patent/SI1521572T1/sl unknown
- 2003-06-30 PT PT03764333T patent/PT1521572E/pt unknown
- 2003-06-30 PL PL374764A patent/PL206379B1/pl not_active IP Right Cessation
- 2003-06-30 EP EP03764333A patent/EP1521572B1/en not_active Expired - Lifetime
- 2003-06-30 ES ES03764333T patent/ES2321083T3/es not_active Expired - Lifetime
- 2003-06-30 CA CA2491312A patent/CA2491312C/en not_active Expired - Fee Related
- 2003-06-30 DK DK03764333T patent/DK1521572T3/da active
- 2003-06-30 KR KR1020057000486A patent/KR101003514B1/ko not_active IP Right Cessation
- 2003-06-30 JP JP2004521510A patent/JP4454019B2/ja not_active Expired - Fee Related
- 2003-06-30 AU AU2003247671A patent/AU2003247671B2/en not_active Ceased
- 2003-06-30 AT AT03764333T patent/ATE424187T1/de active
-
2009
- 2009-04-28 CY CY20091100469T patent/CY1109606T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US8084054B2 (en) | 2011-12-27 |
PT1521572E (pt) | 2009-04-21 |
CY1109606T1 (el) | 2014-08-13 |
PL374764A1 (en) | 2005-10-31 |
ES2321083T3 (es) | 2009-06-02 |
EP1521572B1 (en) | 2009-03-04 |
EP1521572A1 (en) | 2005-04-13 |
DE60326455D1 (de) | 2009-04-16 |
AU2003247671B2 (en) | 2008-02-14 |
JP2005533106A (ja) | 2005-11-04 |
MXPA05000631A (es) | 2005-03-31 |
US20040126408A1 (en) | 2004-07-01 |
KR20050025961A (ko) | 2005-03-14 |
CN100500221C (zh) | 2009-06-17 |
CA2491312A1 (en) | 2004-01-22 |
SI1521572T1 (sl) | 2009-06-30 |
CN1668278A (zh) | 2005-09-14 |
ATE424187T1 (de) | 2009-03-15 |
WO2004006889A1 (en) | 2004-01-22 |
JP4454019B2 (ja) | 2010-04-21 |
AU2003247671A1 (en) | 2004-02-02 |
CA2491312C (en) | 2011-05-31 |
KR101003514B1 (ko) | 2010-12-30 |
PL206379B1 (pl) | 2010-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1521572T3 (da) | Biologisk nedbrydelig film til indförsel af öjenlægemiddel | |
DE60135486D1 (de) | Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung | |
ATE288256T1 (de) | Dermale zusammensetzungen | |
MX344532B (es) | Composiciones de farmaco de liberacion sostenida convenientemente implantables. | |
CY1115707T1 (el) | Στερεα σταθεροποιημενα θεραπευτικα συστηματα ταχειας και/ή τροποποιημενης απελευθερωσης για τη χορηγηση απο του στοματος υγρων δραστικων ουσιων, εκδοχων ή τροφιμων | |
WO2004009445A3 (en) | Packaging and dispensing of rapid dissolve dosage form | |
MA34832B1 (fr) | Compositions biodegradables d'administration de medicaments | |
AU2003237288A1 (en) | Biodegradable block copolymeric compositions for drug delivery | |
DE60330144D1 (de) | Beschichtung von stents mit verzögerter wirkstofffreisetzung | |
WO2008011125A3 (en) | Devices, systems and methods for ophthalmic drug delivery | |
HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
ATE223711T1 (de) | Tts enthaltend ein antioxidans | |
EA200501819A1 (ru) | Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке | |
AR047552A1 (es) | Sistemas de suministro de farmacos de liberacion sostenida biodegradables | |
UA99645C2 (ru) | Гель, имеющий противовоспалительное и противоаллергическое действие | |
WO2006060325A3 (en) | Coated drug delivery formulations | |
DK1957037T3 (da) | Farmaceutisk præparat til nasal anvendelse af fentanyl | |
WO2008027793A3 (en) | Ophthalmic pharmaceutical compositions and uses thereof | |
WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
AU2003256882A1 (en) | Methods of drug delivery using sulphated chitinous polymers | |
UA83036C2 (ru) | Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ | |
TR200601092T1 (tr) | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение |